Panagora Asset Management Inc Oramed Pharmaceuticals Inc. Transaction History

Panagora Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$12.13 - $23.82 $4,985 - $9,790	-411 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$8.34 - $14.59 $800 - $1,400	-96 Reduced 18.93%	411 $5,000
Q4 2020 Feb 10, 2021	BUY	$2.48 - $4.64 $1,257 - $2,352	507 New	507 $2,000
Q3 2019 Nov 12, 2019	SELL	$2.88 - $3.96 $37,048 - $50,941	-12,864 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$2.88 - $4.36 $288 - $436	-100 Reduced 0.77%	12,864 $46,000
Q1 2019 May 15, 2019	BUY	$2.95 - $3.64 $10,929 - $13,486	3,705 Added 40.02%	12,964 $47,000
Q4 2018 Feb 14, 2019	BUY	$3.0 - $4.94 $1,689 - $2,781	563 Added 6.47%	9,259 $28,000
Q3 2018 Nov 13, 2018	BUY	$4.64 - $7.11 $40,349 - $61,828	8,696 New	8,696 $42,000

7.42M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $90.5M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.